CKW Financial Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1K | Buy |
+4
| New | +$527 | ﹤0.01% | 195 |
|
|
2025
Q1 | – | Sell |
-1,900
| Closed | -$176K | – | 215 |
|
|
2024
Q4 | $176K | Hold |
1,900
| – | – | 0.02% | 60 |
|
|
2024
Q3 | $159K | Sell |
1,900
-100
| -5% | -$7.63K | 0.02% | 64 |
|
|
2024
Q2 | $137K | Hold |
2,000
| – | – | 0.02% | 74 |
|
|
2024
Q1 | $146K | Hold |
2,000
| – | – | 0.02% | 71 |
|
|
2023
Q4 | $162K | Hold |
2,000
| – | – | 0.02% | 65 |
|
|
2023
Q3 | $150K | Hold |
2,000
| – | – | 0.02% | 61 |
|
|
2023
Q2 | $154K | Hold |
2,000
| – | – | 0.02% | 68 |
|
|
2023
Q1 | $166K | Hold |
2,000
| – | – | 0.03% | 50 |
|
|
2022
Q4 | $172K | Sell |
2,000
-108
| -5% | -$8.55K | 0.03% | 49 |
|
|
2022
Q3 | $130K | Hold |
2,108
| – | – | 0.02% | 57 |
|
|
2022
Q2 | $131K | Sell |
2,108
-200
| -9% | -$12.4K | 0.02% | 60 |
|
|
2022
Q1 | $138K | Buy |
2,308
+400
| +21% | +$25.6K | 0.02% | 68 |
|
|
2021
Q4 | $140K | Hold |
1,908
| – | – | 0.02% | 60 |
|
|
2021
Q3 | $131K | Buy |
1,908
+508
| +36% | +$35.7K | 0.02% | 64 |
|
|
2021
Q2 | $97K | Buy |
1,400
+600
| +75% | +$40.1K | 0.02% | 80 |
|
|
2021
Q1 | $52K | Hold |
800
| – | – | 0.01% | 102 |
|
|
2020
Q4 | $47K | Buy |
800
+100
| +14% | +$6.03K | 0.01% | 103 |
|
|
2020
Q3 | $44K | Hold |
700
| – | – | 0.01% | 100 |
|
|
2020
Q2 | $53K | Sell |
700
-200
| -22% | -$15.3K | 0.01% | 85 |
|
|
2020
Q1 | $65K | Hold |
900
| – | – | 0.02% | 71 |
|
|
2019
Q4 | $58K | Hold |
900
| – | – | 0.01% | 91 |
|
|
2019
Q3 | $57K | Hold |
900
| – | – | 0.01% | 83 |
|
|
2019
Q2 | $61K | Hold |
900
| – | – | 0.01% | 84 |
|
|
2019
Q1 | $59K | Hold |
900
| – | – | 0.01% | 90 |
|
|
2018
Q4 | $56K | Buy |
+900
| New | +$62.9K | 0.01% | 85 |
|
|
2015
Q3 | – | Sell |
-1,332
| Closed | -$156K | – | 213 |
|
|
2015
Q2 | $156K | Sell |
1,332
-481
| -27% | -$52.6K | 0.06% | 36 |
|
|
2015
Q1 | $177K | Buy |
1,813
+128
| +8% | +$13K | 0.07% | 29 |
|
|
2014
Q4 | $159K | Sell |
1,685
-121
| -7% | -$12.5K | 0.07% | 38 |
|
|
2014
Q3 | $192K | Buy |
1,806
+1,526
| +545% | +$149K | 0.08% | 30 |
|
|
2014
Q2 | $24K | Sell |
280
-1,689
| -86% | -$131K | 0.01% | 181 |
|
|
2014
Q1 | $147K | Buy |
1,969
+1,089
| +124% | +$85.4K | 0.07% | 38 |
|
|
2013
Q4 | $66K | Buy |
+880
| New | +$61.3K | 0.03% | 76 |
|
Other funds holding GILD
CKW Financial Group's GILD Position: Q2 2026 in Review
CKW Financial Group opened a new position in Gilead Sciences (GILD) in Q2 2026: 4 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #195 among its holdings. This is a return to the name: CKW Financial Group previously reported a position in GILD as recently as Q4 2024.
CKW Financial Group first reported a position in GILD in Q4 2013 and has held it in 33 quarters since. The position peaked at $192K in Q3 2014. 2,282 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- CKW Financial Group held 4 shares of Gilead Sciences worth $1K as of Q2 2026.
- Gilead Sciences was a new CKW Financial Group position in Q2 2026.
- Gilead Sciences made up ﹤0.01% of CKW Financial Group's portfolio in Q2 2026, its #195 holding.
- CKW Financial Group first reported a position in Gilead Sciences in Q4 2013 and has held it in 33 quarters since.
- CKW Financial Group's Gilead Sciences position peaked at $192K in Q3 2014.
- 2,282 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on CKW Financial Group's 13F filing for Q2 2026, filed 27 Jul 2026.